Talk:Main Page

From vjmedia
Revision as of 04:09, 7 September 2014 by 116.114.81.125 (talk) (What company are you calling from? http://www.causaabierta.com.uy/catalog/coffein/ buy coffein Despite the rhetoric of transparency and fairness, requirements like these only benefit industry stakeho)

What company are you calling from? http://www.causaabierta.com.uy/catalog/coffein/ buy coffein Despite the rhetoric of transparency and fairness, requirements like these only benefit industry stakeholders, and make it more difficult for health systems to contain pharmaceutical costs. Rising pharmaceutical expenditure brings with it opportunity costs – more money spent on drugs means less to spend on other health services and preventive health care – and the need for increased patient co-payments. In other words, it is people who bear the costs, in one way or another, when the pharmaceutical industry is provided with extra privileges.